Catalyst Wire Dossier Catalyst Wire Dossier

ezabenlimab

ezabenlimab · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for ezabenlimab, covering 2024-07-17 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma [Phase 1]

See pricing